- Home
- RCUS vs PARR Comparison
RCUS vs PARR Comparison
Compare RCUS & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | PARR |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 2.9B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RCUS | PARR |
|---|---|---|
| Price | $24.59 | $84.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $31.90 | ★ $70.17 |
| AVG Volume (30 Days) | ★ 1.1M | 782.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1313.56 |
| EPS | N/A | ★ 10.43 |
| Revenue | $247,000,000.00 | ★ $2,443,066,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.62 | $3.78 |
| P/E Ratio | ★ N/A | $7.97 |
| Revenue Growth | N/A | ★ 30.99 |
| 52 Week Low | $11.30 | $32.24 |
| 52 Week High | $31.74 | $87.03 |
Technical Indicators
Market Signals| Indicator | RCUS | PARR |
|---|---|---|
| Relative Strength Index (RSI) | 33.18 | 62.10 |
| Support Level | $25.94 | $55.45 |
| Resistance Level | $26.43 | $85.37 |
| Average True Range (ATR) | 1.22 | 4.40 |
| MACD | -0.38 | 0.41 |
| Stochastic Oscillator | 0.00 | 90.24 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.